ATE110282T1 - Verfahren zur bestimmung des infarktrisikos. - Google Patents

Verfahren zur bestimmung des infarktrisikos.

Info

Publication number
ATE110282T1
ATE110282T1 AT89908027T AT89908027T ATE110282T1 AT E110282 T1 ATE110282 T1 AT E110282T1 AT 89908027 T AT89908027 T AT 89908027T AT 89908027 T AT89908027 T AT 89908027T AT E110282 T1 ATE110282 T1 AT E110282T1
Authority
AT
Austria
Prior art keywords
risk
procedure
myocardial infarction
miscellaneous
determining
Prior art date
Application number
AT89908027T
Other languages
English (en)
Inventor
Harvey J Berger
Original Assignee
Centocor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centocor Inc filed Critical Centocor Inc
Application granted granted Critical
Publication of ATE110282T1 publication Critical patent/ATE110282T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Amplifiers (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
AT89908027T 1988-06-13 1989-06-09 Verfahren zur bestimmung des infarktrisikos. ATE110282T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/206,437 US5046499A (en) 1988-06-13 1988-06-13 Method for myocardial infarct risk assessment

Publications (1)

Publication Number Publication Date
ATE110282T1 true ATE110282T1 (de) 1994-09-15

Family

ID=22766380

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89908027T ATE110282T1 (de) 1988-06-13 1989-06-09 Verfahren zur bestimmung des infarktrisikos.

Country Status (7)

Country Link
US (1) US5046499A (de)
EP (1) EP0425537B1 (de)
JP (1) JPH03505874A (de)
AT (1) ATE110282T1 (de)
CA (1) CA1336162C (de)
DE (1) DE68917731T2 (de)
WO (1) WO1989012467A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5377681A (en) * 1989-11-13 1995-01-03 University Of Florida Method of diagnosing impaired blood flow
US5277188A (en) * 1991-06-26 1994-01-11 New England Medical Center Hospitals, Inc. Clinical information reporting system
US20020127548A1 (en) * 1992-12-11 2002-09-12 Christine Siedman Methods for detecting mutations associated with hypertrophic cardiomyopathy
US5912121A (en) * 1992-12-11 1999-06-15 Bringham And Women's Hospital Methods for detecting mutations associated with hypertrophic cardiomyopathy
US5594637A (en) * 1993-05-26 1997-01-14 Base Ten Systems, Inc. System and method for assessing medical risk
US5501229A (en) * 1994-08-01 1996-03-26 New England Medical Center Hospital Continuous monitoring using a predictive instrument
US5724983A (en) * 1994-08-01 1998-03-10 New England Center Hospitals, Inc. Continuous monitoring using a predictive instrument
CA2202913C (en) * 1994-10-25 2004-07-13 Hirohisa Katoh Antibody reagent for detecting dissecting aortic aneurysm and uses thereof
AU5530996A (en) * 1995-03-31 1996-10-16 Michael W. Cox System and method of generating prognosis reports for corona ry health management
US5970182A (en) * 1995-11-15 1999-10-19 Focus Imaging, S. A. Registration process for myocardial images
US6270744B1 (en) 1996-02-19 2001-08-07 Yamasa Corporation Diagnostic agent for angiopathic diseases
CA2246665A1 (en) * 1996-02-19 1997-08-21 Hirohisa Katoh Diagnostic agent for digestive diseases
US6727102B1 (en) 1997-06-20 2004-04-27 Leuven Research & Development Vzw Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins
US6309888B1 (en) * 1998-09-04 2001-10-30 Leuven Research & Development Vzw Detection and determination of the stages of coronary artery disease
US7640175B1 (en) * 2000-12-08 2009-12-29 Ingenix, Inc. Method for high-risk member identification
US20030032871A1 (en) * 2001-07-18 2003-02-13 New England Medical Center Hospitals, Inc. Adjustable coefficients to customize predictive instruments
US20030208106A1 (en) * 2002-05-03 2003-11-06 Cortex Biophysik Gmbh Method of cardiac risk assessment
WO2004093687A1 (en) * 2003-04-16 2004-11-04 Eastern Virginia Medical School System and method for generating operator independent ultrasound images
US20050181451A1 (en) * 2004-02-12 2005-08-18 Bates Harold M. Detection of asymptomatic coronary artery disease using atherogenic proteins and acute phase reactants
CN102821680B (zh) * 2010-04-01 2016-05-18 皇家飞利浦电子股份有限公司 用于ecg数据的牛眼图显示
RU2488111C1 (ru) * 2012-05-23 2013-07-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Тверская государственная медицинская академия" Министерства здравоохранения Российской Федерации (ГБОУ ВПО Тверская ГМА Минздрава России) Способ определения риска развития инфаркта миокарда у больных с острым коронарным синдромом
ITPC20120031A1 (it) 2012-12-18 2014-06-19 Leonardo Maffi Metodo per la produzione di pannelli prefabbricati per la realizzazione di vasche circolari e relativo stampo
US20140276122A1 (en) * 2013-03-14 2014-09-18 Pacesetter, Inc. Method and system for neurocardiac differential analysis of ischemia and myocardial infarction
RU2554758C1 (ru) * 2014-04-02 2015-06-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Тверская государственная медицинская академия" Министерства здравоохранения Российской Федерации Способ определения вероятности сохранения миокарда от инфарктного повреждения у больных с острым коронарным синдромом
US10628979B2 (en) 2014-11-04 2020-04-21 Mayo Foundation For Medical Education And Research Computer system and method for diagnostic data display

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4036945A (en) * 1976-05-03 1977-07-19 The Massachusetts General Hospital Composition and method for determining the size and location of myocardial infarcts
US4492753A (en) * 1982-10-06 1985-01-08 Immudx, Inc. Method and means for assessment and prediction of risk of subsequent ischemic cardiac events
JPS6028998A (ja) * 1983-07-06 1985-02-14 Yamasa Shoyu Co Ltd 心筋ミオシン重鎖に対する単一クロ−ン抗体
JPS60201260A (ja) * 1984-03-27 1985-10-11 Yamasa Shoyu Co Ltd 心疾患診断薬
EP0268707A3 (de) * 1985-11-05 1989-03-08 The General Hospital Corporation Negativ geladene spezifische Affinitätsreagenzien

Also Published As

Publication number Publication date
DE68917731T2 (de) 1995-03-30
EP0425537A1 (de) 1991-05-08
JPH03505874A (ja) 1991-12-19
CA1336162C (en) 1995-07-04
DE68917731D1 (de) 1994-09-29
US5046499A (en) 1991-09-10
WO1989012467A1 (en) 1989-12-28
EP0425537B1 (de) 1994-08-24

Similar Documents

Publication Publication Date Title
ATE110282T1 (de) Verfahren zur bestimmung des infarktrisikos.
DE3880306D1 (de) Verfahren und sonde zur ermittlung der austrittsstelle von ventriculaeren tachykardien.
DE3871262D1 (de) Anordnung zur bestimmung und ortung von lecks mittels zeitbereichsreflektometrie und abtasttechnik.
DE69026685D1 (de) Synthetische peptide zum in vivo nachweis von thrombosen
FI870578A7 (fi) Monikasvainkudosviipaleet ja näiden viipaleiden valmistusmenetelmät sekä niissä olevien kudosten testausmenetelmät.
DE69110098D1 (de) Teststreifen zur visuellen Bestimmung der Blutglucosekonzentration.
BR8304354A (pt) Instrumento cirurgico para suturar tecidos e orgaos com grampos
DE69034160D1 (de) Rechnerbasiertes verfahren um die untersuchung von menschlischen brustgewebe nach malignität zu unterstützen
DK8987D0 (da) Lysstraaleklaede for medicinsk behandling
DE3856343D1 (de) Detektionsschaltung zur bestimmung des detektionsabstandes für implantierte elektromedizinische geräte
EP0836723A4 (de) Virtuelles medizinisches instrument zum midizinischen diagnostiktesten von patienten
TR25873A (tr) Kisitli acidan bilgisayarli tomografide cisim sini ri bilgisini elde etme yöntemi
DE3667103D1 (en) Method for determining the turnover of organic material in living tissue and nmr spectrometer for performing this method
DE68927053D1 (de) Separates mri-abbildungsverfahren für wasser bzw. fettgewebe
DE69005840D1 (de) Analytisches Element zur Untersuchung des gesamten Blutes.
DE58906306D1 (de) Vorrichtung zur Bestimmung der Konzentration von zumindest einer in organischem Gewebe vorliegenden Substanz.
AT368190B (de) Pruefmittel zur bestimmung von glucose
DE3667290D1 (de) Boronsaeureaddukte von technetium-99m-dioximkomplexen.
ES2072490T3 (es) Procedimiento para la pasteurizacion de la proteina tisular pp4.
Apple et al. Analyses of creatine kinase isoenzymes and isoforms in serum to detect reperfusion after acute myocardial infarction.
DE3765745D1 (de) Verfahren zur bestimmung der molekular-diffusionsparameter und/oder der durchblutung von lebendem gewebe.
ATE114193T1 (de) Verfahren und testsatz zur bestimmung von tyrosinphosphorylierungs- und dephosphorylierungsaktivitäten.
DE69329656D1 (de) Methoden zur detektion und behandlung von individuen mit abnormalen hla-a2/tyrosinase-peptidantigenen exprimierenden zellen
FI884470L (fi) Biologiskt diagnostiskt analyseringssystem.
ATE106570T1 (de) Verfahren zur bestimmung von fructosamin.